Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xunfei Healthcare Technology CoHKSE:02506 -0.61%6 Return-on-Tangible-Equity is 2.67% as of Dec. 2025. GuruFocus rates HKSE:02506 with a GF Score™ of 6/100. The stock has 3 warning signs investors should review. Among 578 Healthcare Providers & Services companies, Xunfei Healthcare Technology Co ranks worse than 81.66% on this metric.
The historical rank and industry rank for Xunfei Healthcare Technology Co's Return-on-Tangible-Equity or its related term are showing as below:
HKSE:02506'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -113.43 Med: -45.31 Max: -8.97
Current: -8.97
During the past 5 years, Xunfei Healthcare Technology Co's highest Return-on-Tangible-Equity was -8.97%. The lowest was -113.43%. And the median was -45.31%.
HKSE:02506's Return-on-Tangible-Equity is ranked worse than 81.66% of 578
companies
in the Healthcare Providers & Services industry
Industry Median: 10.635
vs HKSE:02506: -8.97
Xunfei Healthcare Technology Co (HKSE:02506) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Xunfei Healthcare Technology Co Return-on-Tangible-Equity Related Terms
Xunfei Healthcare Technology Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xunfei Healthcare Technology Co Return-on-Tangible-Equity Chart
HKSE:02506 vs VEEV, BTSG, HQY: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, Xunfei Healthcare Technology Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xunfei Healthcare Technology Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Xunfei Healthcare Technology Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Xunfei Healthcare Technology Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 2.67% mean?
Xunfei Healthcare Technology Co (HKSE:02506) has a Return-on-Tangible-Equity of 2.67% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Xunfei Healthcare Technology Co and its competitors. According to the industry distribution chart, Xunfei Healthcare Technology Co ranks #472 out of 578 companies in the Healthcare Providers & Services industry, placing it in the top 81.7%.
Is Xunfei Healthcare Technology Co's Return-on-Tangible-Equity too high?
Xunfei Healthcare Technology Co's current Return-on-Tangible-Equity is 2.67%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.64. Xunfei Healthcare Technology Co's value of 2.67% is 74.9% below this industry median. Based on the distribution chart, Xunfei Healthcare Technology Co ranks #472 out of 578 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Xunfei Healthcare Technology Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Xunfei Healthcare Technology Co's Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Xunfei Healthcare Technology Co ranks #472 out of 578 companies for Return-on-Tangible-Equity. This places Xunfei Healthcare Technology Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.64. Xunfei Healthcare Technology Co's value of 2.67% is 74.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.64, based on 578 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xunfei Healthcare Technology Co's current Return-on-Tangible-Equity of 2.67% is 74.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Xunfei Healthcare Technology Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xunfei Healthcare Technology Co's current Return-on-Tangible-Equity is 2.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xunfei Healthcare Technology Co stock overvalued right now?
Xunfei Healthcare Technology Co (HKSE:02506) has a current Return-on-Tangible-Equity of 2.67%. The current Return-on-Tangible-Equity is 2.67% and 74.9% below the Healthcare Providers & Services industry median of 10.64. Xunfei Healthcare Technology Co's overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Xunfei Healthcare Technology Co (HKSE:02506), the current Return-on-Tangible-Equity is 2.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressNo. 666 Science and Innovation Road, High-tech Zone, 4 to 5/F (North Area), No.1 Building, Anhui Province, iFLYTEK AI Research and Development Production Bas, Chengxiqiao Community Services Center, Hefei, CHN
Xunfei Healthcare Technology Co Ltd is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment, and treatment effect evaluation, to post-discharge management and chronic disease management. The company has independently developed AI technologies that underpin its products and solutions including Smart Healthcare, Smart Hospital, Smart Hardware, Smart Medical Insurance, and Smart Film Union.
6GF Score
Get the complete analysis for HKSE:02506
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02506 has been successfully added to your 
